These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 22403631

  • 1. Epidermal growth factor gene polymorphism and risk of hepatocellular carcinoma: a meta-analysis.
    Zhong JH, You XM, Gong WF, Ma L, Zhang Y, Mo QG, Wu LC, Xiao J, Li LQ.
    PLoS One; 2012; 7(3):e32159. PubMed ID: 22403631
    [Abstract] [Full Text] [Related]

  • 2. Association between epidermal growth factor gene +61A/G polymorphism and the risk of hepatocellular carcinoma: a meta-analysis based on 16 studies.
    Jiang G, Yu K, Shao L, Yu X, Hu C, Qian P, Xie H, Li J, Zheng J, Zheng S.
    BMC Cancer; 2015 Apr 25; 15():314. PubMed ID: 25927412
    [Abstract] [Full Text] [Related]

  • 3. Meta-analysis of microsomal epoxide hydrolase gene polymorphism and risk of hepatocellular carcinoma.
    Zhong JH, Xiang BD, Ma L, You XM, Li LQ, Xie GS.
    PLoS One; 2013 Apr 25; 8(2):e57064. PubMed ID: 23451147
    [Abstract] [Full Text] [Related]

  • 4. Association between the epidermal growth factor 61*A/G polymorphism and hepatocellular carcinoma risk: a meta-analysis.
    Sun S, Jin GJ, Zhao Y, Kang H.
    Asian Pac J Cancer Prev; 2015 Apr 25; 16(7):3009-14. PubMed ID: 25854398
    [Abstract] [Full Text] [Related]

  • 5. Epidermal growth factor 61A>G polymorphism is associated with risk of hepatocellular carcinoma: a meta-analysis.
    Yang Z, Wu Q, Shi Y, Nie Y, Wu K, Fan D.
    Genet Test Mol Biomarkers; 2012 Sep 25; 16(9):1086-91. PubMed ID: 22852842
    [Abstract] [Full Text] [Related]

  • 6. Association between the EGF rs4444903 polymorphism and liver cancer susceptibility: a meta-analysis and meta-regression.
    Li YL, Tian Z, Zhao L, Zhang CL.
    Genet Mol Res; 2014 Oct 07; 13(4):8066-79. PubMed ID: 25299191
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Association between epidermal growth factor gene rs4444903 polymorphism and risk of glioma.
    Hu M, Shi H, Xu Z, Liu W.
    Tumour Biol; 2013 Jun 07; 34(3):1879-85. PubMed ID: 23645212
    [Abstract] [Full Text] [Related]

  • 9. Epidermal growth factor +61 G/A polymorphism and the risk of hepatocellular carcinoma in a Chinese population.
    Chen K, Wei Y, Yang H, Li B.
    Genet Test Mol Biomarkers; 2011 Apr 07; 15(4):251-5. PubMed ID: 21186997
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis.
    Xie T, Wang ZG, Zhang JL, Liu H.
    World J Gastroenterol; 2012 Aug 21; 18(31):4207-14. PubMed ID: 22919255
    [Abstract] [Full Text] [Related]

  • 13. Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis.
    Tanabe KK, Lemoine A, Finkelstein DM, Kawasaki H, Fujii T, Chung RT, Lauwers GY, Kulu Y, Muzikansky A, Kuruppu D, Lanuti M, Goodwin JM, Azoulay D, Fuchs BC.
    JAMA; 2008 Jan 02; 299(1):53-60. PubMed ID: 18167406
    [Abstract] [Full Text] [Related]

  • 14. XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis.
    Liu F, Li B, Wei Y, Yan L, Wen T, Zhao J, Xu M.
    Liver Int; 2011 Jul 02; 31(6):802-9. PubMed ID: 21645210
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Association of interleukin-6 gene polymorphisms with the risk of hepatocellular carcinoma: An up-to-date meta-analysis.
    An PP, Feng LN, Zhang XX, Jin QL.
    Medicine (Baltimore); 2020 Dec 11; 99(50):e23659. PubMed ID: 33327352
    [Abstract] [Full Text] [Related]

  • 17. A functional polymorphism in the epidermal growth factor gene is associated with risk for hepatocellular carcinoma.
    Abu Dayyeh BK, Yang M, Fuchs BC, Karl DL, Yamada S, Sninsky JJ, O'Brien TR, Dienstag JL, Tanabe KK, Chung RT, HALT-C Trial Group.
    Gastroenterology; 2011 Jul 11; 141(1):141-9. PubMed ID: 21440548
    [Abstract] [Full Text] [Related]

  • 18. The XRCC1 Arg399Gln genetic polymorphism contributes to hepatocellular carcinoma susceptibility: an updated meta-analysis.
    Pan Y, Zhao L, Chen XM, Gu Y, Shen JG, Liu LM.
    Asian Pac J Cancer Prev; 2013 Jul 11; 14(10):5761-7. PubMed ID: 24289575
    [Abstract] [Full Text] [Related]

  • 19. Lack of association of EPHX1 gene polymorphisms with risk of hepatocellular carcinoma: a meta-analysis.
    Duan CY, Liu MY, Li SB, Ma KS, Bie P.
    Tumour Biol; 2014 Jan 11; 35(1):659-66. PubMed ID: 23955801
    [Abstract] [Full Text] [Related]

  • 20. Association between the risk of hepatitis virus-related hepatocellular carcinoma and EGF polymorphism: A PRISMA-compliant updated meta-analysis.
    Wang Q, Xu L, Wu Q, Zhang M, Zhang J.
    Medicine (Baltimore); 2022 Oct 21; 101(42):e31280. PubMed ID: 36281156
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.